Ferguson JE, Kelley RW, Patterson C. Mechanisms of endothelial differentiation in embryonic vasculogenesis. Arterioscler Thromb Vasc Biol. 2005; 25: 2246–2254. Abstract/FREE Full Text
Jiang BH, Rue E, Wang GL, Roe R, Semenza GL (July 1996). „Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1”. J. Biol. Chem.271 (30): 17771–8. DOI:10.1074/jbc.271.30.17771. PMID8663540.
Herbst RS, Onn A, Sandler A (2005). „Angiogenesis and lung cancer: prognostic and therapeutic implications”. J. Clin. Oncol.23 (14): 3243–56. DOI:10.1200/JCO.2005.18.853. PMID15886312. *Pufe T, Kurz B, Petersen W i dr.. (2006). „The influence of biomechanical parameters on the expression of VEGF and endostatin in the bone and joint system”. Ann. Anat.187 (5–6): 461–72. DOI:10.1016/j.aanat.2005.06.008. PMID16320826.
Matsumoto T, Mugishima H (2006). „Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis”. J. Atheroscler. Thromb.13 (3): 130–5. DOI:10.5551/jat.13.130. PMID16835467.
Ria R, Roccaro AM, Merchionne F i dr.. (2003). „Vascular endothelial growth factor and its receptors in multiple myeloma”. Leukemia17 (10): 1961–6. DOI:10.1038/sj.leu.2403076. PMID14513045.
nature.com
Coffin JD, Poole TJ. Endothelial cell origin and migration in embryonic heart and cranial blood vessel development. Anat Rec. 1991; 231: 383–395.CrossRefMedline,Abstract
nejm.org
(en) Sang H. Lee, Paul L. Wolf, Ryan Escudero, Reena Deutsch, Stuart W. Jamieson, Patricia A. Thistlethwaite, Early Expression of Angiogenesis Factors in Acute Myocardial Ischemia and Infarction, N Engl J Med 2000; 342:626-633March 2, 2000DOI: 10.1056/NEJM200003023420904 [1] Pristupljeno 16. 9. 2013.
Coffin JD, Poole TJ. Endothelial cell origin and migration in embryonic heart and cranial blood vessel development. Anat Rec. 1991; 231: 383–395.CrossRefMedline,Abstract
Jiang BH, Rue E, Wang GL, Roe R, Semenza GL (July 1996). „Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1”. J. Biol. Chem.271 (30): 17771–8. DOI:10.1074/jbc.271.30.17771. PMID8663540.
Herbst RS, Onn A, Sandler A (2005). „Angiogenesis and lung cancer: prognostic and therapeutic implications”. J. Clin. Oncol.23 (14): 3243–56. DOI:10.1200/JCO.2005.18.853. PMID15886312. *Pufe T, Kurz B, Petersen W i dr.. (2006). „The influence of biomechanical parameters on the expression of VEGF and endostatin in the bone and joint system”. Ann. Anat.187 (5–6): 461–72. DOI:10.1016/j.aanat.2005.06.008. PMID16320826.
Matsumoto T, Mugishima H (2006). „Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis”. J. Atheroscler. Thromb.13 (3): 130–5. DOI:10.5551/jat.13.130. PMID16835467.
Ria R, Roccaro AM, Merchionne F i dr.. (2003). „Vascular endothelial growth factor and its receptors in multiple myeloma”. Leukemia17 (10): 1961–6. DOI:10.1038/sj.leu.2403076. PMID14513045.